Introduction. According to Kovalenko et al. (2016) cardiovascular diseases have been among the leading causes of mortality in Ukraine for many years. An important role in their occurrence belongs to the negative "achievements" of modern society: hypodynamia, increased caloric content of food products, chronic mental stress…etc. The indicated well-known factors contribute to the unceasing increase in the incidence of coronary artery disease (CAD) arterial hypertension, obesity, diabetes mellitus, dyslipidemia. Clinical trials convincingly point to the important role of reduced hemoglobin level in the progression of cardiovascular diseases. Anemia is recognized as an independent predictor of a high risk of fatal cardiovascular events developing during 6 years in non-cardiovascular patients, especially those aged 45-64. In the PRAISE study in patients with severe chronic heart failure with decreased hematocrit to 25.4-37.4%, the risk of sudden death was 52% higher than with its high value (46.1-58.8%). In addition, the reduction of this figure by 1% below 25.4% was accompanied by an increase in the risk of mortality by 11%. Anemia is associated with increased all-cause hospitalization and mortality in community-dwelling individuals above the age of 65. It is known by Gandhi et al. (2017) that in primary care offices higher prevalence of anemia is associated with advancing age and comorbidities, such as essential hypertension, hypothyroidism, chronic kidney disease, malignancy, rheumatologic disease, congestive heart failure, and coronary artery disease. In the large population with stable CAD, according to Nappi (2003) and Kalra et al. (2017) , low hemoglobin is an independent predictor of mortality, cardiovascular events, and major bleeds. Persisting or new-onset anemia is a powerful predictor of cardiovascular and non-cardiovascular mortality. Aim: to determine the incidence and characteristic features of anemic syndrome (AS) in patients with CAD of elderly and senile age.
Material and Methods of Investigation
An unicenter retrospective study of 1993 patient records of illnesses was carried out. Patients were undergoing inpatient treatment in the cardiological department of the Regional Hospital for Disabled Soldiers of the Great Patriotic War (Chernivtsi, Ukraine) from January to December 2014. All patients were diagnosed with chronic CAD, which was represented by stable angina pectoris II-III functional classes (according to the classification of the Canadian Association of Cardiologists, 1976), as well as diffuse and focal (post-infarction) cardiosclerosis. The age of the patients ranged from 60 to 96 years (average age 79.5±5.24 years). Comorbid anemia was diagnosed in case of hemoglobin level below 130 G/l in males and 120 G/l in females (WHO's Recommendations, 2003) . Distribution of patients by age is given in Figure 1 . The data from 252 elderly patients (60-74 years old) -12.64% and 1700 senile patients (75-89 years old) -85.30% were analyzed. In addition, the investigation included records of the hospitalized patients over the age of 90 (2.06%). Gender distribution of the patients is represented in Figure 2 . 
Males Females
Source: Author
Results of the Investigation
Among all examined patients, AS was found in 69.89% (1393 cases), which coincides with the literature data. Among male patients, anemia occurred in 1120 cases, which was 77.24%; among women it occurred in 273 cases (50.28%). It was established that in people after the age of 60, anemia is more common in men than in women, whereas it is a well-known fact that in adolescents and young adults AS occurs more frequently in females. Mild anemia (hemoglobin level 90-120 (130) G/l) was the most frequent comorbid pathology in patients with CAD (1317 cases, 94.54%). Moderate degree of anemia severity (hemoglobin level 70-90 G/l) occurred in 65 cases (4.67%). In 11 CAD patients, severe anemia (hemoglobin level less than 70 G/l) was found (0.79%). Among males, mild anemia was detected in 1065 cases (95.09%), moderate anemia -in 49 cases (4.37%), severe anemia -in 6 cases (0.54%). In women, anemia of mild degree occurred in 92.31% (252 cases), moderate -5.86% (16 cases), severe degree -1.83% (5 cases).
Only in less than a hundred case reports, the diagnosis of AS was recorded in the final clinical diagnosis during the patients' discharge from the hospital. Mild anemia was documented as a separate diagnosis in only 37 patients among 1317 (2.81%) (Figure 3) . Moderate anemia was present as a separate diagnosis in about 2/3 of all cases (in 42 patients out of 65). Approximately one-third of all cases (36.36%) of severe anemia were not diagnosed in a hospital and no appropriate correction of hemoglobin level was performed (Figure 4 ). Comparing the incidence of the comorbid anemia depending on the form of chronic CAD, we have found out that anemia in approximately equal percent of cases complicated the course of stable angina pectoris and post-infarction or diffuse cardiosclerosis (Table 1) . Comparing the degree of saturation of erythrocytes with hemoglobin, the hyperchromic character of anemia (color index>1.05) was detected in 22 patients (1.58%), hypochromic (color index<0.86) -in 116 patients (8.33%). In most cases anemia in patients with CAD was of normochromic character -1255 cases (90.09%) ( Figure 5 ). To determine the morphological characteristics of the AS in patients with chronic forms of CAD, the erythrocytes mean corpuscular volume (MCV) was calculated. Mild macrocytosis (MCV=95-108 fl) cases cases % % was detected only in several cases -19 patients, (1.36%), microcytosis (MCV<80 fl) -in 157 patients (11.27%), normocytosis was found in 1217 cases (87.37%) ( Figure 6 ). Thus, in most patients with CAD, comorbid anemia is of a normochromic and normocytic character. The average duration of the in-hospital treatment of the patients with CAD without anemia was 16.14±0.03 days. Along with the progression of the severity of the comorbid anemia, a statistically significant increase of the hospitalization period was observed. So, if CAD was accompanied by mild anemia, the average in-hospital treatment duration was 18.23±0.050 days, moderate anemia -20.02±0.077, severe anemia -21.03 ± 0.100. In patients with CAD and comorbid anemia, the frequency of hospitalizations per year was also increased. Thus, among all patients with CAD without anemia, 85.50% of the patients were hospitalized twice a year due to the main disease, 43.01% -three times per year, 24.33% -four times per year, 0.33% -more than four times. On the other hand, in the case of CAD with concomitant anemia, 94.54% of patients were admitted to the hospital twice a year, 55.20% -three times, 33.17% -four times, 3.88% -more often. Among all analyzed cases, in the largest number of them (79.83%) CAD and anemia were comorbid with chronic obstructive pulmonary disease, 28.14% of patients suffered from peptic ulcers of the stomach and duodenum, 4.31% of patients had oncological pathology of various localization, and in 20.32% of cases anemia and CAD were isolated. (2013) . This fact shows an increased risk of death and major clinical adverse events among elderly patients with stable symptomatic CAD (Muzzarelli S., Pfisterer M. (2006) . In older patients with CAD, anemic syndrome is most often caused by respiratory diseases (79.83%), stomach and duodenal ulcers (28.14%), and cancer of various localizations (4.31%). Concomitant anemia in patients with CAD contributes to the prolongation of the patients' in-hospital treatment and increases of the frequency of hospitalizations due to the main disease throughout the year. References
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